Carl Zeiss MicroImaging launched a new technology that delivers high-content analyses to research microscopes. ASSAYbuilder is a suite of next generation High-Content Analyses (HCA) tools that can be added to any microscope with a digital imaging package including AxioVision.
Leveraging the power of research microcopy for high-content analyses promises to enable precise assay development and hit qualification for the screening community while reducing the cost of access for academics that need greater flexibility when imaging and analyzing biological targets.
This article was published in Drug Discovery & Development magazine: Vol. 11, No. 2, February, 2008, pp. 17.
Filed Under: Drug Discovery
